Greenyn Biotechnology, established in 2012, is a leading Taiwanese company specializing in the research, development, and production of health food ingredients. In 2023, the company was publicly listed with the stock code 6846. Greenyn offers over 100 internationally renowned branded ingredients and more than 300 commonly used materials, providing professional ODM health food design and manufacturing services. The company focuses on developing health ingredients with Taiwanese characteristics and international competitiveness, delivering customized, high-efficacy products to meet the diverse needs of the end market. A key competitive advantage of Greenyn lies in its self-developed and self-produced health ingredients. The company is among the few in Taiwan investing in the research and development of internationally certified health ingredients. By targeting niche markets and emphasizing product differentiation, Greenyn has successfully created market demand. Notably, the patented Sequenced 19 Peptide (bitter melon peptide) has gained significant traction in the domestic market, capturing approximately 20% market share and expanding sales across Asia. Greenyn’s products adhere to international standards and are validated through scientific data to ensure efficacy and safety. The company holds 96 international patents and publishes research findings in international professional journals. Greenyn aligns with global regulations, obtaining approvals such as the U.S. FDA New Dietary Ingredient (NDI), Japan’s Food with Function Claims (FFC), and Korea’s Health Functional Food (HFF) certifications, facilitating market promotion and development in various countries. In terms of marketing and sales, Greenyn provides a one-stop design and manufacturing service, offering clients customized formulations and assisting in creating differentiated products. The company supports clients with professional nutritionist consultations, marketing assistance, and educational training, ensuring high-quality control and compliance with international regulations. This comprehensive service enhances customer loyalty and satisfaction. Internationally, Greenyn has established distribution channels in 12 countries, including Thailand, Vietnam, the Philippines, Malaysia, Singapore, Japan, New Zealand, and Australia. The company collaborates with local distributors to develop markets, obtaining import permits and increasing overseas sales. In recent years, overseas sales have grown by nearly 50%, with revenue contribution surpassing 10%. The Southeast and Northeast Asian markets show particularly promising growth. To meet growing demand, Greenyn plans to construct a new factory in the Tanza Juxing Industrial Park. With the expansion of production capacity, the company anticipates a significant increase in operational scale, further solidifying its position in the health food industry.

Self-developed patented ingredients: Bitter melon extract (Insumate®)-Blood sugar management Antrodia cinnamomea mycelia(Antromax®)-Liver care 101 Phyto Fermented Drink(Zymologist®)-Gut health and anti-oxidiant Crassocephalum rabens (RabenWhite®)-Beauty Citrusvel® (HPMF™)-Weight management